Trial Results

Protocol
Available Languages: English
Statistical Analysis Plan
Available Languages: English

Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants

Study Identifier:
WTX101-HV-106
ClinicalTrials.gov Identifier:
EudraCT Identifier:
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete

Study Details

Medical Condition
  • Unmapped
Study Drug
  • Drug: ALXN1840
Date
Feb 2019 - May 2019
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 45 Years
Requirements Information
Sex
Female & Male
Age
18 - 45 Years

Study Details

Medical Condition
  • Unmapped
Study Drug
  • Drug: ALXN1840
Date
Feb 2019 - May 2019
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 45 Years years
Requirements Information

Protocol Summary

The main purpose of the study is to confirm how long ALXN1840 stays in the body of Japanese and non-Japanese healthy participants (that is, pharmacokinetic \[PK\] profile).

Trial Locations

Location
Status
Location
Richmond Pharmacology Ltd., St George's University of London
London, United Kingdom
Status
N/A